On January 11, 2023, a United States District Judge for the Central District of California granted DAE’s motion for a preliminary injunction on behalf of a pharmaceutical client against a former employee.  DAE alleged that the former employee had, among other things, misappropriated the client’s trade secrets and violated the federal Computer Fraud and Abuse Act.  The District Court found that DAE’s client had demonstrated a substantial likelihood of success on the merits of its claims.  DAE attorneys Michael Amir and Jason Baim were the attorneys of record on this matter.